GTEX-1F48J
|
51-60
|
Female
|
GTEX-1F48J-1726 |
Liver
|
PAXgene |
1
|
2 pieces; severe macrovesicular steatosis
|
Acceptable
|
|
GTEX-1F52S
|
61-70
|
Female
|
GTEX-1F52S-1926 |
Liver
|
PAXgene |
2
|
2 pieces; severe central congestion and atrophy
|
Acceptable
|
|
GTEX-1F5PL
|
41-50
|
Female
|
GTEX-1F5PL-0626 |
Liver
|
PAXgene |
1
|
2 pieces established cirrhosis with diffuse marked macrovesicular steatosis
|
Acceptable
|
|
GTEX-1F6I4
|
51-60
|
Male
|
GTEX-1F6I4-1226 |
Liver
|
PAXgene |
2
|
2 pieces; congestion, mild to moderate steatosis
|
Acceptable
|
|
GTEX-1F6IF
|
61-70
|
Male
|
GTEX-1F6IF-1926 |
Liver
|
PAXgene |
1
|
2 pieces, moderate passive congestion
|
Acceptable
|
|
GTEX-1F6RS
|
61-70
|
Female
|
GTEX-1F6RS-1326 |
Liver
|
PAXgene |
1
|
2 pieces; focally moderate autolysis
|
Acceptable
|
|
GTEX-1F75A
|
51-60
|
Male
|
GTEX-1F75A-1626 |
Liver
|
PAXgene |
2
|
2 pieces, marked passive congestion, focal areas with early infarction
|
Acceptable
|
|
GTEX-1F75B
|
51-60
|
Male
|
GTEX-1F75B-1326 |
Liver
|
PAXgene |
2
|
2 pieces; congestion
|
Acceptable
|
|
GTEX-1F75W
|
61-70
|
Male
|
GTEX-1F75W-1426 |
Liver
|
PAXgene |
1
|
2 pieces; bridging periportal fibrosis
|
Acceptable
|
|
GTEX-1F7RK
|
21-40
|
Female
|
GTEX-1F7RK-0726 |
Liver
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
|
GTEX-1F88E
|
61-70
|
Female
|
GTEX-1F88E-1526 |
Liver
|
PAXgene |
1
|
2 pieces, moderate diffuse passive congestion
|
Acceptable
|
|
GTEX-1F88F
|
61-70
|
Female
|
GTEX-1F88F-0626 |
Liver
|
PAXgene |
1
|
2 pieces; 5% macrovesicular steatosis
|
Acceptable
|
|
GTEX-1GF9V
|
61-70
|
Male
|
GTEX-1GF9V-1226 |
Liver
|
PAXgene |
1
|
2 pieces, ~50% macrovesicular steatosis; moderate passive congestion
|
Acceptable
|
|
GTEX-1GF9W
|
61-70
|
Male
|
GTEX-1GF9W-0826 |
Liver
|
PAXgene |
1
|
2 pieces; extensive hemorrhagic central necrosis
|
Acceptable
|
|
GTEX-1GF9X
|
41-50
|
Female
|
GTEX-1GF9X-0426 |
Liver
|
PAXgene |
1
|
2 pieces; severe (>75%) macrovesicular steatosis
|
Acceptable
|
|
GTEX-1GMR3
|
21-40
|
Male
|
GTEX-1GMR3-1026 |
Liver
|
PAXgene |
1
|
2 pieces, moderate passive congestion
|
Acceptable
|
|
GTEX-1GMR8
|
51-60
|
Female
|
GTEX-1GMR8-1526 |
Liver
|
PAXgene |
2
|
2 pieces; nodular cirrhosis; transplant 2011; hemochromatosis per history
|
Unacceptable
|
|
GTEX-1GMRU
|
51-60
|
Male
|
GTEX-1GMRU-0926 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse macrovesicular steatosis involves ~80% of parenchyma
|
Acceptable
|
|
GTEX-1GN1U
|
51-60
|
Female
|
GTEX-1GN1U-0926 |
Liver
|
PAXgene |
1
|
2 pieces, moderate/focally marked passive congestion, cardiac features
|
Acceptable
|
|
GTEX-1GN1V
|
61-70
|
Male
|
GTEX-1GN1V-1226 |
Liver
|
PAXgene |
1
|
2 pieces; moderate steatosis
|
Acceptable
|
|
GTEX-1GN2E
|
61-70
|
Male
|
GTEX-1GN2E-0926 |
Liver
|
PAXgene |
1
|
2 pieces, centrilobular macrovesicular steatosis involves ~20-30% of parenchyma
|
Acceptable
|
|
GTEX-1GN73
|
61-70
|
Male
|
GTEX-1GN73-1126 |
Liver
|
PAXgene |
1
|
2 pieces; <5% macrovesicular steatosis; focal hemorrhages
|
Acceptable
|
|
GTEX-1GPI6
|
61-70
|
Male
|
GTEX-1GPI6-1326 |
Liver
|
PAXgene |
1
|
2 pieces, moderately advanced passive congestion
|
Acceptable
|
|
GTEX-1GTWX
|
61-70
|
Male
|
GTEX-1GTWX-1126 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse macrovesicular steatosis involves ~60% of parenchyma; moderate passive congestion
|
Acceptable
|
|
GTEX-1GZ2Q
|
41-50
|
Male
|
GTEX-1GZ2Q-1326 |
Liver
|
PAXgene |
1
|
2 pieces; fatty degeneration, fibrosis consistent with cirrhosis, and inflammation
|
Unacceptable
|
|